Crosina Jordan, Lerner Jordyn, Ho Julie, Tangri Navdeep, Komenda Paul, Hiebert Brett, Choi Nora, Arora Rakesh C, Rigatto Claudio
Department of Medicine, University of Manitoba, Winnipeg, Canada.
Department of Immunology, University of Manitoba, Winnipeg, Canada.
Kidney Int Rep. 2016 Oct 21;2(2):172-179. doi: 10.1016/j.ekir.2016.10.003. eCollection 2017 Mar.
Acute kidney injury (AKI) is a potentially fatal complication of cardiac surgery. The inability to predict cardiac surgery-associated AKI is a major barrier to prevention and early treatment. Current clinical risk models for the prediction of cardiac surgery-associated AKI are insufficient, particularly in patients with preexisting kidney dysfunction.
To identify intraoperative variables that might improve the performance of a validated clinical risk score (Cleveland Clinic Score, CCS) for the prediction of cardiac surgery-associated AKI, we conducted a prospective cohort study in 289 consecutive elective cardiac surgery patients at a tertiary care center. We compared the area under the receiver operator characteristic curve (AUC) of a base model including only the CCS with models containing additional selected intraoperative variables including mean arterial pressure, hematocrit, duration of procedure, blood transfusions, and fluid balance. AKI was defined by the Kidney Disease Improving Global Outcomes 2012 criteria.
The CCS alone gave an AUC of 0.72 (95% confidence interval, 0.62-0.82) for postoperative AKI. Nadir intraoperative hematocrit was the only variable that improved AUC for postoperative AKI when added to the CCS (AUC = 0.78; 95% confidence interval, 0.70-0.87; = 0.002). In the subcohort of patients without preexisting chronic kidney disease (n = 214), where the CCS underperformed (AUC, 0.60 [0.43-0.76]), the improvement with the addition of nadir hematocrit was more marked (AUC, 0.74 [0.62-0.86]). Other variables did not improve discrimination.
Nadir intraoperative hematocrit is useful in improving discrimination of clinical risk scores for AKI, and may provide a target for intervention.
急性肾损伤(AKI)是心脏手术的一种潜在致命并发症。无法预测心脏手术相关的AKI是预防和早期治疗的主要障碍。目前用于预测心脏手术相关AKI的临床风险模型并不充分,尤其是在已有肾功能不全的患者中。
为了确定可能改善用于预测心脏手术相关AKI的经过验证的临床风险评分(克利夫兰诊所评分,CCS)性能的术中变量,我们在一家三级医疗中心对289例连续择期心脏手术患者进行了一项前瞻性队列研究。我们将仅包含CCS的基础模型的受试者操作特征曲线下面积(AUC)与包含额外选定术中变量(包括平均动脉压、血细胞比容、手术持续时间、输血和液体平衡)的模型进行了比较。AKI根据2012年改善全球肾脏病预后组织的标准定义。
仅CCS对术后AKI的AUC为0.72(95%置信区间,0.62 - 0.82)。术中最低血细胞比容是添加到CCS时唯一能改善术后AKI的AUC的变量(AUC = 0.78;95%置信区间,0.70 - 0.87;P = 0.002)。在无既往慢性肾脏病的亚组患者(n = 214)中,CCS表现不佳(AUC,0.60 [0.43 - 0.76]),添加最低血细胞比容后的改善更为显著(AUC,0.74 [0.62 - 0.86])。其他变量并未改善辨别能力。
术中最低血细胞比容有助于改善对AKI临床风险评分的辨别能力,并可能提供干预靶点。